Full text is available at the source.
Upregulation of eIF2α by m6A modification accelerates the proliferation of pulmonary artery smooth muscle cells in MCT-induced pulmonary arterial hypertension rats
Increase of a protein-making regulator by m6A modification speeds growth of lung artery muscle cells in rats with induced pulmonary hypertension
AI simplified
Abstract
Eukaryotic initiation factor 2α (eIF2α) is markedly upregulated in monocrotaline-induced pulmonary arterial hypertension (PAH) rats.
- Upregulated eIF2α is linked to increased proliferation of pulmonary artery smooth muscle cells in PAH.
- The regulatory mechanism of eIF2α involves mRNA methylation.
- Inhibition of eIF2α using GSK2606414 reduces its expression and decreases smooth muscle cell proliferation.
- Bioinformatics analysis reveals a common sequence between eIF2α mRNA and N 6-methyladenosine modification.
- Increased expression of METTL3, WTAP, and YTHDF1 is observed in monocrotaline-induced PAH rats.
AI simplified